Predicting Re-Exacerbation Timing and Understanding Prolonged Exacerbations: An Analysis of Patients with COPD in the ECLIPSE Cohort

References

• Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease; 2021. Available from: https://goldcopd.org/wp-content/uploads/2020/11/GOLD-REPORT-2021-v1.1-25Nov20_WMV.pdf. Accessed January 14, 2021.
   Google Scholar
• GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 2018;392(10159):1789–1858. doi:10.1016/S0140-6736(18)32279-7
   PubMed Web of Science ®Google Scholar
• Wedzicha JA, Seemungal TA. COPD exacerbations: defining their cause and prevention. Lancet. 2007;370(9589):786–796. doi:10.1016/S0140-6736(07)61382-8
   PubMed Web of Science ®Google Scholar
• Seemungal TA, Donaldson GC, Bhowmik A, et al. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;161(5):1608–1613. doi:10.1164/ajrccm.161.5.9908022
   PubMed Web of Science ®Google Scholar
• Rothnie KJ, Mullerova H, Smeeth L, et al. Natural history of chronic obstructive pulmonary disease exacerbations in a general practice-based population with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2018;198(4):464–471. doi:10.1164/rccm.201710-2029OC
   PubMed Web of Science ®Google Scholar
• Ramsey SD, Sullivan SD. The burden of illness and economic evaluation for COPD. Eur Respir J Suppl. 2003;41:29s–35s. doi:10.1183/09031936.03.00078203
   PubMedGoogle Scholar
• Strassels SA, Smith DH, Sullivan SD, et al. The costs of treating COPD in the United States. Chest. 2001;119(2):344–352. doi:10.1378/chest.119.2.344
   PubMed Web of Science ®Google Scholar
• Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128–1138. doi:10.1056/NEJMoa0909883
   PubMed Web of Science ®Google Scholar
• Suissa S, Dell’Aniello S, Ernst P. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax. 2012;67(11):957–963. doi:10.1136/thoraxjnl-2011-201518
   PubMed Web of Science ®Google Scholar
• Erdal M, Johannessen A, Eagan TM, et al. Incidence of utilization- and symptom-defined COPD exacerbations in hospital- and population-recruited patients. Int J Chron Obstruct Pulmon Dis. 2016;11:2099–2108. doi:10.2147/COPD.S108720
   PubMed Web of Science ®Google Scholar
• Halpin DM, Miravitlles M, Metzdorf N, et al. Impact and prevention of severe exacerbations of COPD: a review of the evidence. Int J Chron Obstruct Pulmon Dis. 2017;12:2891–2908. doi:10.2147/COPD.S139470
   PubMed Web of Science ®Google Scholar
• Han MK, Quibrera PM, Carretta EE, et al. Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort. Lancet Respir Med. 2017;5(8):619–626. doi:10.1016/S2213-2600(17)30207-2
   PubMed Web of Science ®Google Scholar
• Hartley BF, Barnes NC, Lettis S, et al. Risk factors for exacerbations and pneumonia in patients with chronic obstructive pulmonary disease: a pooled analysis. Respir Res. 2020;21(1):5. doi:10.1186/s12931-019-1262-0
   PubMed Web of Science ®Google Scholar
• Jinjuvadia C, Jinjuvadia R, Mandapakala C, et al. Trends in outcomes, financial burden, and mortality for acute exacerbation of chronic obstructive pulmonary disease (COPD) in the United States from 2002 to 2010. COPD. 2017;14(1):72–79. doi:10.1080/15412555.2016.1199669
   PubMedGoogle Scholar
• Make BJ, Eriksson G, Calverley PM, et al. A score to predict short-term risk of COPD exacerbations (SCOPEX). Int J Chron Obstruct Pulmon Dis. 2015;10:201–209. doi:10.2147/COPD.S69589
   PubMed Web of Science ®Google Scholar
• Stanford RH, Korrer S, Brekke L, et al. Validation and assessment of the COPD treatment ratio as a predictor of severe Exacerbations. Chronic Obstr Pulm Dis. 2020;7(1):38–48. doi:10.15326/jcopdf.7.1.2019.0132
   PubMed Web of Science ®Google Scholar
• Worth H, Buhl R, Criee CP, et al. GOLD 2017 treatment pathways in ‘real life’: an analysis of the DACCORD observational study. Respir Med. 2017;131:77–84. doi:10.1016/j.rmed.2017.08.008
   PubMed Web of Science ®Google Scholar
• Lindenauer PK, Dharmarajan K, Qin L, et al. Risk trajectories of readmission and death in the first year after hospitalization for chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2018;197(8):1009–1017. doi:10.1164/rccm.201709-1852OC
   PubMed Web of Science ®Google Scholar
• Seymour JM, Moore L, Jolley CJ, et al. Outpatient pulmonary rehabilitation following acute exacerbations of COPD. Thorax. 2010;65(5):423–428. doi:10.1136/thx.2009.124164
   PubMed Web of Science ®Google Scholar
• Liu D, Peng SH, Zhang J, et al. Prediction of short term re-exacerbation in patients with acute exacerbation of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2015;10:1265–1273. doi:10.2147/COPD.S83378
   PubMed Web of Science ®Google Scholar
• Almagro P, Cabrera FJ, Diez J, et al. Comorbidities and short-term prognosis in patients hospitalized for acute exacerbation of COPD: the EPOC en servicios de medicina interna (ESMI) study. Chest. 2012;142(5):1126–1133. doi:10.1378/chest.11-2413
   PubMed Web of Science ®Google Scholar
• Johannesdottir SA, Christiansen CF, Johansen MB, et al. Hospitalization with acute exacerbation of chronic obstructive pulmonary disease and associated health resource utilization: a population-based Danish cohort study. J Med Econ. 2013;16(7):897–906. doi:10.3111/13696998.2013.800525
   PubMedGoogle Scholar
• Baker CL, Zou KH, Su J. Risk assessment of readmissions following an initial COPD-related hospitalization. Int J Chron Obstruct Pulmon Dis. 2013;8:551–559. doi:10.2147/COPD.S51507
   PubMed Web of Science ®Google Scholar
• Meeraus W, Benson V, Tabberer M, et al. How are recovery and recurrence of COPD exacerbations defined in observational studies? A systematic review. Eur Respir J. 2018;52:PA1167.
   Web of Science ®Google Scholar
• Meeraus W, Mullerova H, Tabberer M, et al. Systematic review of COPD re-exacerbation and exacerbation treatment failure definitions used in randomised controlled trials (RCTs). Eur Respir J. 2018;52:PA1171.
   Web of Science ®Google Scholar
• Donaldson GC, Wedzicha JA. COPD exacerbations.1: epidemiology. Thorax. 2006;61(2):164–168. doi:10.1136/thx.2005.041806
   PubMed Web of Science ®Google Scholar
• Bollmeier SG, Hartmann AP. Management of chronic obstructive pulmonary disease: a review focusing on exacerbations. Am J Health Syst Pharm. 2020;77(4):259–268. doi:10.1093/ajhp/zxz306
   PubMed Web of Science ®Google Scholar
• Incalzi RA, Pedone C, Onder G, et al. Predicting length of stay of older patients with exacerbated chronic obstructive pulmonary disease. Aging (Milano). 2001;13(1):49–57.
   PubMedGoogle Scholar
• Crisafulli E, Ielpo A, Barbeta E, et al. Clinical variables predicting the risk of a hospital stay for longer than 7 days in patients with severe acute exacerbations of chronic obstructive pulmonary disease: a prospective study. Respir Res. 2018;19(1):261. doi:10.1186/s12931-018-0951-4
   PubMed Web of Science ®Google Scholar
• Wang Y, Stavem K, Dahl FA, et al. Factors associated with a prolonged length of stay after acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Int J Chron Obstruct Pulmon Dis. 2014;9:99–105. doi:10.2147/COPD.S51467
   PubMed Web of Science ®Google Scholar
• Vestbo J, Anderson W, Coxson HO, et al. Evaluation of COPD longitudinally to identify predictive surrogate end-points (ECLIPSE). Eur Respir J. 2008;31(4):869–873. doi:10.1183/09031936.00111707
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease; 2009.
   Google Scholar
• Agusti A, Calverley PM, Celli B, et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res. 2010;11(1):122. doi:10.1186/1465-9921-11-122
   PubMed Web of Science ®Google Scholar
• Peterson B, Harrell JF. Partial proportional odds models for ordinal response variables. J Royal Stat Soc. 1990;39(2):205–217.
   Google Scholar
• Derr B. Ordinal response modeling with the LOGISTIC procedure. SAS Global Forum; 2013. San Francisco. Available from: https://support.sas.com/resources/papers/proceedings13/446-2013.pdf. Accessed December 31, 2020.
   Google Scholar
• Donaldson GC, Law M, Kowlessar B, et al. Impact of prolonged exacerbation recovery in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;192(8):943–950. doi:10.1164/rccm.201412-2269OC
   PubMed Web of Science ®Google Scholar
• Wise RA, Calverley PM, Carter K, et al. Seasonal variations in exacerbations and deaths in patients with COPD during the TIOSPIR® trial. Int J Chron Obstruct Pulmon Dis. 2018;13:605–616. doi:10.2147/COPD.S148393
   PubMed Web of Science ®Google Scholar
• Rabe KF, Fabbri LM, Vogelmeier C, et al. Seasonal distribution of COPD exacerbations in the prevention of exacerbations with tiotropium in COPD trial. Chest. 2013;143(3):711–719. doi:10.1378/chest.12-1277
   PubMed Web of Science ®Google Scholar
• Jenkins CR, Celli B, Anderson JA, et al. Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study. Eur Respir J. 2012;39(1):38–45. doi:10.1183/09031936.00194610
   PubMed Web of Science ®Google Scholar
• Ko FW, Chan KP, Hui DS, et al. Acute exacerbation of COPD. Respirology. 2016;21(7):1152–1165. doi:10.1111/resp.12780
   PubMed Web of Science ®Google Scholar
• Hicks A, Healy E, Sandeman N, et al. A time for everything and everything in its time – exploring the mechanisms underlying seasonality of COPD exacerbations. Int J Chron Obstruct Pulmon Dis. 2018;13:2739–2749. doi:10.2147/COPD.S146015
   PubMed Web of Science ®Google Scholar
• McIlvennan CK, Eapen ZJ, Allen LA. Hospital readmissions reduction program. Circulation. 2015;131(20):1796–1803. doi:10.1161/CIRCULATIONAHA.114.010270
   PubMed Web of Science ®Google Scholar
• Roberts CM, Lowe D, Bucknall CE, et al. Clinical audit indicators of outcome following admission to hospital with acute exacerbation of chronic obstructive pulmonary disease. Thorax. 2002;57(2):137–141. doi:10.1136/thorax.57.2.137
   PubMed Web of Science ®Google Scholar
• Säynäjäkangas O, Kinnunen T, Tuuponen T, et al. Length of stay and interval to readmission in emergency hospital treatment of COPD. Age Ageing. 2004;33(6):567–570. doi:10.1093/ageing/afh188
   PubMed Web of Science ®Google Scholar
• Wong AW, Gan WQ, Burns J, et al. Acute exacerbation of chronic obstructive pulmonary disease: influence of social factors in determining length of hospital stay and readmission rates. Can Respir J. 2008;15(7):361–364. doi:10.1155/2008/569496
   PubMed Web of Science ®Google Scholar
• Ruparel M, Lopez-Campos JL, Castro-Acosta A, et al. Understanding variation in length of hospital stay for COPD exacerbation: European COPD audit. ERJ Open Res. 2016;2(1):1. doi:10.1183/23120541.00034-2015
   Google Scholar
• Kotz D, Simpson CR, Viechtbauer W, et al. Development and validation of a model to predict the 10-year risk of general practitioner-recorded COPD. NPJ Prim Care Respir Med. 2014;24(1):14011. doi:10.1038/npjpcrm.2014.11
   PubMedGoogle Scholar
• Himes BE, Dai Y, Kohane IS, et al. Prediction of chronic obstructive pulmonary disease (COPD) in asthma patients using electronic medical records. J Am Med Inform Assoc. 2009;16(3):371–379. doi:10.1197/jamia.M2846
   PubMed Web of Science ®Google Scholar
• Annavarapu S, Goldfarb S, Gelb M, et al. Development and validation of a predictive model to identify patients at risk of severe COPD exacerbations using administrative claims data. Int J Chron Obstruct Pulmon Dis. 2018;13:2121–2130. doi:10.2147/COPD.S155773
   PubMed Web of Science ®Google Scholar